Automotive Industry Today
SEE OTHER BRANDS

Your best source on automotive industry news from the world

Automotive Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.

Press releases published on April 1, 2025

Cygnus bénéficie de deux années supplémentaires pour accroître sa participation dans Pontax

Cygnus bénéficie de deux années supplémentaires pour accroître sa participation dans Pontax

Projet de lithium Pontax, Baie James, Canada TORONTO et PERTH, Australie-Occidentale, 01 avr. 2025 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5, TSXV: CYG, OTCQB: CYGGF) est heureuse d'annoncer qu'elle a négocié une prolongation de deux ans de son …

Refined Living, Inc. Announces Plans to Build Thousands of Residential Units Across Connecticut and Massachusetts

Refined Living, Inc. Announces Plans to Build Thousands of Residential Units Across Connecticut and Massachusetts

HARTFORD, Conn., April 01, 2025 (GLOBE NEWSWIRE) -- Refined Living, Inc., a real estate development firm led by veteran broker and investor Robert Letskus, has announced its plan to build thousands of new residential units across Connecticut and …

Tenaris Files 2024 Annual Report / Annual Report on Form 20-F, and Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

Tenaris Files 2024 Annual Report / Annual Report on Form 20-F, and Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

LUXEMBOURG, April 01, 2025 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) filed today its 2024 Annual Report / Annual Report on Form 20-F, with the Luxembourg Stock Exchange, with the U.S. Securities and Exchange Commission (SEC …

Tenaris Presenta el Informe Anual 2024 / Informe Anual 2024 en formulario 20-F, y Convoca a la Asamblea General Anual de Accionistas y a una Asamblea General Extraordinaria de Accionistas

Tenaris Presenta el Informe Anual 2024 / Informe Anual 2024 en formulario 20-F, y Convoca a la Asamblea General Anual de Accionistas y a una Asamblea General Extraordinaria de Accionistas

LUXEMBURGO, April 01, 2025 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE y Mexico: TS y EXM Italia: TEN) presentó hoy su informe anual 2024 / informe anual 2024 en formulario 20-F, ante la Bolsa de Valores de Luxemburgo (Luxembourg Stock Exchange), ante la …

Hesai Group Files Its Annual Report on Form 20-F

Hesai Group Files Its Annual Report on Form 20-F

SHANGHAI, China, April 01, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it filed its annual report on Form 20-F …

NowVertical Reports Record 2024 Financial Results

NowVertical Reports Record 2024 Financial Results

Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …

Florida Mesothelioma Victims Center Urges a Person Who Had Workplace Exposure to Asbestos in a State Outside of Florida and Now Has Mesothelioma or Lung Cancer to Call the Gori Law Firm-Expect Better Compensation

Florida Mesothelioma Victims Center Urges a Person Who Had Workplace Exposure to Asbestos in a State Outside of Florida and Now Has Mesothelioma or Lung Cancer to Call the Gori Law Firm-Expect Better Compensation

ORLANDO , FL, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center is urging the family of an individual who has just discovered they have mesothelioma or lung cancer to please call the Gori Law Firm at 866-532-2106 …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report

Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report

Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-Year Adjusted EBITDA Loss Improved by 32.4% Versus Prior Year Significant Balance Sheet Transformation Underway in 2025 PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (OTC: …

Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025

Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2025 operating and financial results on Monday, May 5, 2025, after market close. The Company will host a …

Western Forest Products Inc. Announces Release Date of First Quarter 2025 Results and Conference Call Details

Western Forest Products Inc. Announces Release Date of First Quarter 2025 Results and Conference Call Details

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) first quarter 2025 financial and operating results will be released on Tuesday, May 6, 2025. Western will host its first …

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …

Volatus Aerospace to Present at the AI & Technology Virtual Investor Conference on April 3rd

Volatus Aerospace to Present at the AI & Technology Virtual Investor Conference on April 3rd

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (OTCQX: TAKOF) (TSXV: FLT) (Frankfurt: ABB), a leader in innovative aerial solutions, invites individual and institutional investors, as well as analysts and advisors, to join the AI …

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …

Volatus Aerospace présentera à la conférence virtuelle des investisseurs en IA et technologies le 3 avril

Volatus Aerospace présentera à la conférence virtuelle des investisseurs en IA et technologies le 3 avril

TORONTO, 01 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (OTCQX : TAKOF) (TSXV : FLT) (Frankfurt : ABB), un leader dans les solutions aériennes innovantes, invite les investisseurs institutionnels et individuels, ainsi que les analystes et …

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …

Mullen Group Ltd. 2025 First Quarter Earnings Conference Call and Webcast

Mullen Group Ltd. 2025 First Quarter Earnings Conference Call and Webcast

OKOTOKS, Alberta, April 01, 2025 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. ("Mullen Group" and/or the "Corporation") intends to release its 2025 First Quarter earnings results on Wednesday, April 23, 2025, at 6:00 a.m. ET, and has scheduled a …

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces …

New Toll Brothers Luxury Home Community Coming Soon to Santa Clara, California

New Toll Brothers Luxury Home Community Coming Soon to Santa Clara, California

SANTA CLARA, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its highly anticipated Northern California community, 3131 Camino, a luxury neighborhood of townhome-style …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service